Human Papilloma Virus (HPV) vaccination in Italy: towards new perspectives and new challenges | Zendy

Vittoria Colamesta | Zendy; Adriano Grossi | Zendy; Andréa Barbará | Zendy; Anna Acampora | Zendy; Francesco Andrea Causio | Zendy; Giovanna Elisa Calabrò | Zendy; Chiara de Waure | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Human Papilloma Virus (HPV) vaccination in Italy: towards new perspectives and new challenges

Author(s) -

Vittoria Colamesta,

Adriano Grossi,

Andréa Barbará,

Anna Acampora,

Francesco Andrea Causio,

Giovanna Elisa Calabrò,

Chiara de Waure

Publication year - 2022

Publication title -

epidemiology biostatistics and public health

Language(s) - English

Resource type - Journals

eISSN - 2282-2305

pISSN - 2282-0930

DOI - 10.2427/13021

Subject(s) - genital warts , human papilloma virus , hpv infection , sex organ , vaccination , hpv vaccines , medicine , virology , public health , cervical cancer , papilloma , virus , human papillomavirus , immunology , cancer , biology , pathology , genetics

Human Papilloma virus (HPV) is the cause of a sexually transmitted infection which can lead to the development of genital warts, anogenital and oropharyngeal cancers. In Europe, about 90% of HPV-related cancers and 90% of genital warts are estimated to be vaccine preventable each year. In Italy, around 5,000 cases of cancers are due to HPV infections each year. This explains why HPV infection control is considered a public health priority.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research